Springbok Capital Management »

Acrivon Therapeutics shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $93k 13k 7.15